Brigade Enterprises Limited's Nomination and Remuneration Committee has approved significant employee stock option plan (ESOP) activities, including the allotment of equity shares and granting of new stock options during its meeting held on January 29, 2026.

ESOP Share Allotment Details

The committee approved the allotment of equity shares under two separate ESOP schemes, totaling 95,191 shares. The allotment was distributed across the company's existing employee stock option plans.

Impact on Share Capital

The allotment resulted in an increase in the company's paid-up share capital. Following the ESOP share allotment, the paid-up share capital increased from Rs. 2,44,49,82,730 to Rs. 2,44,59,34,640.

New Stock Options Grant

The committee also approved the issuance of 98,564 stock options under the Employee Stock Option Plan rolled out in 2022. These options were granted to eligible employees of the group as part of the company's employee incentive program.

Regulatory Compliance

The stock option grants are in accordance with the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations 2021. The exercise price of Rs. 395 per share was previously fixed by the Nomination and Remuneration Committee in its meeting held on May 11, 2022, in compliance with SEBI regulations.

The options are governed by the Brigade Employee Stock Option Plan, which received in-principle approval from stock exchanges and was approved by shareholders through a postal ballot on May 4, 2022. The granted options will vest based on performance criteria being met, with a five-year exercise window from the date of vesting for each tranche.

Meeting Details

The Nomination and Remuneration Committee meeting commenced at 3:30 p.m. and concluded at 4:35 p.m. on January 29, 2026. The company has informed both the National Stock Exchange of India Limited and BSE Limited about these developments as part of its regulatory disclosure obligations under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Brigade enterprises has announced its board meeting schedule and trading window closure in compliance with regulatory requirements for the upcoming quarterly results disclosure.

Board Meeting Details

The company's Board of Directors is scheduled to meet on January 30, 2026, to consider and approve several key financial documents. The meeting agenda includes review of unaudited standalone and consolidated financial results for specific reporting periods.

Trading Window Restrictions

In accordance with insider trading prevention measures, Brigade Enterprises has implemented a trading window closure for designated persons. This restriction affects specific categories of individuals who may have access to unpublished price-sensitive information.

Conference Call Announcement

The company has scheduled an investor conference call to discuss its financial and operational performance following the board meeting. Senior management will participate in this discussion to provide insights into the quarterly results.

Dial-in Information

The company has provided comprehensive dial-in details for both domestic and international participants:

India Access Numbers:

• Universal Access: +91 22 6280 1209
• Alternative: +91 22 7115 8110

International Toll-free Numbers:

• United Kingdom: 0 808 101 1573
• USA: 1 866 746 2133
• Singapore: 800 101 2045
• Hong Kong: 800 964 448

Participants are advised to dial 5-10 minutes prior to the scheduled start time to ensure proper connection to the call.

Regulatory Compliance

The announcement demonstrates Brigade Enterprises' adherence to regulatory requirements under SEBI guidelines. The company has notified both National Stock Exchange of India Limited and BSE Limited about these developments, maintaining transparency with stakeholders and ensuring compliance with listing obligations.